| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/13/1997 | CA2228056A1 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridinecarboxamide, process for preparation thereof and pharmaceutical composition containing said compound |
| 02/13/1997 | CA2228048A1 Process for preparing solid dosage forms of very low-dose drugs |
| 02/13/1997 | CA2228034A1 Transdermal patch containing aspirin |
| 02/13/1997 | CA2227989A1 Liposomal oligonucleotide compositions |
| 02/13/1997 | CA2227980A1 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone |
| 02/13/1997 | CA2227972A1 Mocarhagin, a cobra venom protease and therapeutic uses thereof |
| 02/13/1997 | CA2227958A1 Compositions containing analgesics and antihistamines and methods for treating respiratory disorders |
| 02/13/1997 | CA2227877A1 Pyridine compounds, intermediates, processes, compositions, and methods |
| 02/13/1997 | CA2227871A1 Mucosal delivery of polynucleotides |
| 02/13/1997 | CA2227808A1 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 02/13/1997 | CA2227769A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227751A1 Use of calendula glycosides for the treatment of psoriasis |
| 02/13/1997 | CA2227694A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227369A1 Inhibitors of farnesyl-protein transferase |
| 02/13/1997 | CA2227364A1 Cyclic peptide anti-fungal agents |
| 02/13/1997 | CA2226892A1 Method of detecting lung disease |
| 02/13/1997 | CA2226624A1 Methods for treatment of allergic asthma |
| 02/13/1997 | CA2225555A1 Quinolones and their therapeutic use |
| 02/13/1997 | CA2225552A1 Quinolones and their therapeutic use |
| 02/13/1997 | CA2225465A1 Benzimidazole compounds |
| 02/13/1997 | CA2224909A1 Ha-2 antigenic peptide |
| 02/13/1997 | CA2224894A1 The h-y antigen |
| 02/13/1997 | CA2224293A1 Use of agonists or antagonists of p2 purinoceptors for the prevention of glutamate-evoked cytotoxicity |
| 02/13/1997 | CA2223968A1 Bowman-birk inhibitor compositions for treatment of inflammatory disease |
| 02/13/1997 | CA2201478A1 New carboxamides with antifungal activity |
| 02/12/1997 | EP0757991A1 Bioavailable crystalline form of cefuroxime axetil |
| 02/12/1997 | EP0757990A1 7-(1-Pyrrolidoinyl)-3-quinolone and naphthyridone carboxylic acid derivatives, method for their preparation and for substituted mono- and bicyclic pyrrolidine intermediates, and their antibacterial and feed additive compositions |
| 02/12/1997 | EP0757982A1 Biphenylic compounds, process for their preparations and intermediates for this process, their use as 5-alpha-reductase inhibitors and pharmaceutical compositions containing them |
| 02/12/1997 | EP0757911A1 New galenic formulations containing fenofibrate and their applications |
| 02/12/1997 | EP0757718A1 Methods of use of uncoated gel particles |
| 02/12/1997 | EP0757692A1 Methanol derivatives for treatment of retroviral infections especially hiv infections |
| 02/12/1997 | EP0757690A1 Electron-deficient porphyrins and processes and intermediates for preparing same |
| 02/12/1997 | EP0757689A1 Porphocyanine and cnc-expanded porphyrins |
| 02/12/1997 | EP0757688A1 Method for stabilizing compound dx-52-1 and lyophilized composition thereof |
| 02/12/1997 | EP0757687A1 Tricyclic derivatives as 5ht 2c? and 5ht 2b? antagonists |
| 02/12/1997 | EP0757686A1 Benzofuran derivatives as d 4? receptor antagonists |
| 02/12/1997 | EP0757685A1 Novel acyclic and cyclic amides as neurotransmitter release enhancers |
| 02/12/1997 | EP0757682A1 Benzofuran derivatives useful as inhibitors of bone resorption |
| 02/12/1997 | EP0757681A1 CONDENSED HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE AS GnRH ANTAGONISTS |
| 02/12/1997 | EP0757677A1 Benzocycloalkylazolethione derivatives |
| 02/12/1997 | EP0757676A1 Dihydrodibenzo(de,h)isoquinolines derivatives and their use as anti-cancer agents |
| 02/12/1997 | EP0757675A1 Novel quinolone 5-(n-heterosubstituted amino) antimicrobials |
| 02/12/1997 | EP0757674A1 SUBSTITUTED SULFONAMIDES AS SELECTIVE $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 02/12/1997 | EP0757670A1 Benzamide derivatives as vasopressin antagonists |
| 02/12/1997 | EP0757669A1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them |
| 02/12/1997 | EP0757560A1 Use of amidoamines in ophthalmic compositions |
| 02/12/1997 | EP0757558A1 Screening methods for integumental inflammation modulating agents |
| 02/12/1997 | EP0757557A1 Methods for inducing t cell tolerance to a tissue or organ graft |
| 02/12/1997 | EP0757555A1 A method for sustained and extended corneal analgesia |
| 02/12/1997 | EP0717991A4 Neurotropic agent and process for producing it |
| 02/12/1997 | EP0663908B1 Method of preparing taxane derivatives |
| 02/12/1997 | EP0603414B1 (-)-ritodrine |
| 02/12/1997 | EP0589933B1 Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides |
| 02/12/1997 | EP0546179B1 4-o-(aminoglycosyl)- or 4,6-di-o-(aminoglycosyl)-2,5-dideoxy-5,5-difluorostreptamine derivative and production thereof |
| 02/12/1997 | EP0544681B1 A novel salicylic acid-maltol conjugates |
| 02/12/1997 | CN1142833A Poly-beta-1-4-N-acetylglucosamine |
| 02/12/1997 | CN1142828A Tetrahydrofuran antifungals |
| 02/12/1997 | CN1142827A HIV protease inhibitors |
| 02/12/1997 | CN1142826A Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 02/12/1997 | CN1142825A Neuroprotective chroman compounds |
| 02/12/1997 | CN1142824A 3-substituted 1-arylindole compounds |
| 02/12/1997 | CN1142823A 5-heteroarylindole derivatives as benzodiazepine receptor site agonists and analagonists |
| 02/12/1997 | CN1142822A Cyclic amide derivatives as neurokinin A antagonists |
| 02/12/1997 | CN1142820A Crystalline N-acetyl neuraminic acid derivatives and process for their preparation |
| 02/12/1997 | CN1142819A Morpholine and thiomorpholine tachykinin receptor antagonists |
| 02/12/1997 | CN1142817A 1N-alkyl-N-arylpyrimidinamines and derivatives thereof |
| 02/12/1997 | CN1142816A Crystalline, polymorphic form of (S,S,S)-n-(1-|2-carboxy-3-(n2-mesyllysylamino)propyl¨-1-cyclopenlylcarbonyl)tyrosine |
| 02/12/1997 | CN1142771A Lyophilized stem cell factor formulations |
| 02/12/1997 | CN1142769A Pharmaceuticals |
| 02/12/1997 | CN1142768A Use of PLA2 inhibitors as treatment for Alzheimer's disease |
| 02/12/1997 | CN1142767A Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis |
| 02/12/1997 | CN1142766A Combined antipyretic analgesic drug |
| 02/12/1997 | CN1142765A inflammatory cytokine production inhibitor containing polyprenyl derivative as active ingredient |
| 02/12/1997 | CN1142764A Sucrose ester C-zo to C-28 alcohol formulations |
| 02/12/1997 | CN1142501A Novel sulphuric acid esters of amino-sugars |
| 02/12/1997 | CN1142499A Tricyclic 5,6-dihydro-9H-pyrazolo|3,4-c¨-1,2,4,-triaolo (4,3-alpha¨ pyridines |
| 02/12/1997 | CN1142498A (Thiophen-2-yl-)-piperidin or tetrahydropyridin azabicyclocarboxamides |
| 02/12/1997 | CN1142496A New thiophene compounds, process for their preparation and pharmaceutical compositions containing them |
| 02/12/1997 | CN1142495A Platelet activating factor antagonist and preparation thereof |
| 02/12/1997 | CN1142494A New Piperazine, piperidine and 1,2,5,6-tetrahydropyridine compounds, process for preparation thereof and pharmaceutical compositions containing them |
| 02/12/1997 | CN1142493A Arylalkylpyridzinones |
| 02/12/1997 | CN1142492A Substituted N-(indole-2-carbonyl)-glycinamides and derivatives as antidiabetic agents |
| 02/12/1997 | CN1142362A Prescription and usage of Chuerjing eye drop |
| 02/12/1997 | CN1142360A Medical composition for treating burn and scald without scars |
| 02/12/1997 | CN1142359A Pellets of nifedipine |
| 02/12/1997 | CN1142358A Pellets of captopril |
| 02/12/1997 | CN1034016C Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids |
| 02/12/1997 | CA2183012A1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules |
| 02/11/1997 | US5602275 May be used to accelerate recovery from neutropenia accompanying radio- or chemotherapy, bone marrow transplantation or infections |
| 02/11/1997 | US5602259 Method for producing 4-hydroxy-5-methyl-3[2H]-furanone and uses of same |
| 02/11/1997 | US5602257 Reacting piperidone aminal with nicotinic acid derivative to form aminal nicotinoyl piperidone salt; forming anabaseine salt |
| 02/11/1997 | US5602254 Method for making quinoline carboxylic acids or naphthyridine carboxylic acids in free base form |
| 02/11/1997 | US5602253 Peptides derivatives |
| 02/11/1997 | US5602250 6-(substituted methylene)penems and intermediates |
| 02/11/1997 | US5602184 Monoterpenes, sesquiterpenes and diterpenes as cancer therapy |
| 02/11/1997 | US5602183 Diaper dermatitis; mixture of antiinflammatory agent andpyruvate compound, antioxidant and fatty acids |
| 02/11/1997 | US5602182 Containing a combination of polyethylene glycol and sodium carboxymethylcellulose |
| 02/11/1997 | US5602180 Method of administering EDTA complexes |
| 02/11/1997 | US5602179 Optically-active derivatives of (R) 5-pentylamino-5-oxopentanoic acid with antagonistic activity towards cholecystokinin and a method for their preparation |
| 02/11/1997 | US5602178 Bath products containing menthyl lactate |